GAITHERSBURG, Md., June 2, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer, will present at the following event:
| Event: | Jefferies 2014 Global Healthcare Conference | |
| Date: | June 5, 2014 | |
| Time: | 9:00 am ET | |
| Webcast: | www.novavax.com, via "Investor Info/Events" tab |
A replay of the conference call will be available from 9:30 am on June 5, 2014 until midnight September 5, 2014 and can be found on the "Investor Info/Events" tab on the Novavax website.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company creating novel vaccines and vaccine adjuvants to address a broad range of infectious diseases worldwide. Using innovative proprietary recombinant protein nanoparticle vaccine technology, the company produces vaccine candidates to efficiently and effectively respond to both known and newly emergent diseases. Additional information about Novavax is available on the company's website, novavax.com.